Bluejay Diagnostics, Inc. BJDX 深 沪
交易中 08-10 10:55:41 美东时间
1.01
-0.060
-5.61%
华盛通- 最 高1.69
- 今 开1.05
- 成交量 38.13万股
- 最 低 0.9093
- 昨 收 1.07
- 总市值 2.04万
- 52周最高 7.00
- 市盈率 静 --
- 换手率 1891.95%
- 52周最低 0.6273
- 委 比 -80.51%
- 总股本 2.02万
- 历史最高 13.9799
- 量 比 0.11
- 振 幅 72.96%
- 历史最低 0.0652
- 每 手 1
- 风险率 0.98%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Bluejay Diagnostics Completes Patient Enrollment In SYMON-II Multicenter Clinical Validation Study
Bluejay Diagnostics, Inc. (NASDAQ:BJDX), a medical diagnostics company developing rapid, near-patient diagnostic technologies for critical care, today announced the successful completion of patient enrollment in its
07-21 18:35
Market-Moving News for June 2nd
HPE: 30% | Hewlett Packard Enterprise shares are trading higher after the company reported better-than-expected Q2 financial results BJDX: 200% | Bluejay Diagnostics Announces Strategic Partnership With
06-02 19:24
Bluejay Diagnostics Announces 1-For-4 Reverse Stock Split, Effective Jan. 29
Bluejay Diagnostics, Inc. (NASDAQ: BJDX) ("Bluejay" or the "Company"), a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care settings, today
01-27 21:04
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Adlai Nortye (NASDAQ:ANL) stock moved upwards by 44.5% to $2.37 during...
2025-12-29 20:05
Bluejay Diagnostics Provides Mid-Year Business and Corporate Update
Bluejay Diagnostics provides a mid-year update, highlighting advancements in its SYMON-II clinical trial for its Symphony IL-6 test, aiming to predict sepsis mortality. The company plans a 510(k) FDA submission by Q4 2027 and approval by Q3 2028. It is also working on manufacturing improvements and seeking $30 million in financing. The company has reduced its workforce to conserve cash and announced its 2025 Annual Meeting for stockholder approvals.
2025-06-03 20:05
Why Zhibao Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
Shares of Zhibao Technology Inc. (NASDAQ:ZBAO) rose sharply in today's pre-market trading after the company announced that it has won a tender to provide high-end medical third party administration services to the People’s Insurance Company of China Limited. Zhibao Technology shares jumped 18.8% to ...
2024-09-03 17:13
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Conduit Pharmaceuticals (NASDAQ:CDT) stock increased by 27.4% to $0.16 during Monday's after-market session. The company's market cap stands at $15.0 million. TNF Pharmaceuticals (NASDAQ:TNFA) stock moved upwards by 18.82% to $2.02. The market value of their outstanding shares is at $4.7 mil...
2024-09-03 04:31
